QuidelOrtho Corporation (QDEL)
Nasdaq: QDEL · In Vitro & In Vivo Diagnostic Substances · San Diego, CA · filing with the SEC since 2022
Grade4.8
◀ Past 5.8● Present 5.0▶ Future 3.6
Who owns QuidelOrtho Corporation
As filed with the SECHolders of 5% or more
7
Blackrock, Inc. holds 14.8% of Common Stock, as its SCHEDULE 13G/A filed Jul 17, 2025 says.
Directors and officers
19
report now, of 29 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 17, 2025 · Common Stock · 12.5% in Feb 5, 2025
Newtyn Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock · 7.8% in May 6, 2026
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Fmr LLC
SCHEDULE 13G/A · filed Oct 7, 2026 · COMMON STOCK · 11.5% in May 7, 2026
Rubric Capital Management LP
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.001 per share · 6.86% in Jul 9, 2025
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Invesco LTD
SCHEDULE 13G · filed Aug 13, 2026 · Common Stock · 4.6% in May 6, 2026
Neuberger Berman Group LLC
SCHEDULE 13G/A · filed Aug 5, 2026 · Common · reported falling below 5%, from 5.2% in Jul 8, 2026
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · COMMON STOCK · reported falling below 5%, from 8.3% in Apr 8, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 11.5% in Jul 29, 2025
What QDEL reports owning in othersstakes of 5% or more, and other ties
77 subsidiaries in 39 countries, from the list filed with the 10-K filed Feb 19, 2026.
Insider tradesForm 4
1sales
9purchases
0sales on a scheduled plan
1people selling
$100,000sold, in dollars
$1.3Mbought, in dollars
Open-market trades on Form 4 from Oct 19, 2025 to Oct 19, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 19, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 38 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Widder Kenneth J | director | 1 | $100,000 | 0 | 0 | $0 |
| Busky Joseph M | Chief Financial Officer | 0 | $0 | 0 | 3 | $300,000 |
| Blaser Brian J. | President and CEO | 0 | $0 | 0 | 2 | $800,000 |
| Polan Mary Lake Ph D | director | 0 | $0 | 0 | 1 | $0 |
| Rhoads Ann D | director | 0 | $0 | 0 | 1 | $0 |
| Wilkins Joseph D Jr. | director | 0 | $0 | 0 | 1 | $0 |
| Strobeck Matthew | director | 0 | $0 | 0 | 1 | $200,000 |